Cartalax 20mg
AED tripeptide (Ala-Glu-Asp) — 20mg per vial Khavinson-lineage cartilage bioregulator Research-grade · Purity verified by HPLC For in vitro research only
For laboratory research use only. Not for human or veterinary consumption. SKU LAX20.
Product details.
The bioregulator premise
The proposition is that a tripeptide this small can reach the nucleus and influence gene expression in a tissue-selective way — for Cartalax, the target tissue is cartilage and connective tissue. Cell-culture work has reported shifts in chondrocyte gene expression consistent with matrix synthesis over matrix breakdown, including raised IGF1 expression in aging human stem cells. It is a smaller and more specialised literature than the mainstream peptides in this catalog, which is worth stating plainly.
Specifications
| Sequence | Ala-Glu-Asp (AED) |
| Class | Short peptide bioregulator (cytomedine lineage) |
| Target tissue | Cartilage / connective tissue |
| Form | Lyophilized powder |
| Quantity | 20mg per vial |
| Solubility | Soluble in water |
Research areas
Chondrocyte gene expression
The core of the published work — whether AED shifts the balance of matrix synthesis versus degradation in cartilage cell models.
Cellular aging
IGF1 expression in aging stem cell populations, the finding most often cited from this line of research.
Handling
Reconstitute with bacteriostatic water. Store the lyophilized vial refrigerated. Short peptides are generally stable but should not be repeatedly freeze-thawed in solution.
Research use only
Sold strictly as a research chemical for in vitro laboratory investigation. Not a drug, food, cosmetic or dietary supplement. Not for human or veterinary use.
FDA Disclaimer. All products are for research use only (RUO) as defined by the FDA — not for diagnostic, human, or veterinary use. These products have not been evaluated and have not been approved by the U.S. Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.
Heritage Labs is a chemical supplier providing products strictly for laboratory research, analytical, and in-vitro purposes; it is not a compounding pharmacy or compounding facility under Section 503A, nor an outsourcing facility under Section 503B, of the Federal Food, Drug, and Cosmetic Act.